These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21182973)

  • 1. Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network.
    Horwitz EM; Horowitz MM; DiFronzo NL; Kohn DB; Heslop HE;
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):192-6. PubMed ID: 21182973
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
    Simari RD; Moyé LA; Skarlatos SI; Ellis SG; Zhao DX; Willerson JT; Henry TD; Pepine CJ
    J Cardiovasc Transl Res; 2010 Feb; 3(1):30-6. PubMed ID: 20445812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
    Weisdorf D; Carter S; Confer D; Ferrara J; Horowitz M
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):257-62; discussion 255-6. PubMed ID: 17317578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.
    Bennette CS; Ramsey SD; McDermott CL; Carlson JJ; Basu A; Veenstra DL
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26714555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2015 Nov; 45(11):1001-6. PubMed ID: 26423340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.
    O'Donnell PV; Eapen M; Horowitz MM; Logan BR; DiGilio A; Brunstein C; Fuchs EJ; Flowers ME; Salit R; Raj K; Pagliuca A; Bradstock K; Granata A; Castagna L; Furst S; Blaise D
    Bone Marrow Transplant; 2016 Dec; 51(12):1599-1601. PubMed ID: 27526284
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regenerative medicine for blood diseases].
    Saito H
    Nihon Rinsho; 2003 Mar; 61(3):494-7. PubMed ID: 12701179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From evidence to clinical practice in blood and marrow transplantation.
    Khera N
    Blood Rev; 2015 Nov; 29(6):351-7. PubMed ID: 25934009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Your tax dollars at work! or the APPLES trial bears fruit.
    Phillips B
    J Clin Sleep Med; 2008 Oct; 4(5):419-20. PubMed ID: 18853697
    [No Abstract]   [Full Text] [Related]  

  • 10. Umbilical cord blood transplantation in cancer therapy.
    Hexner EO
    Clin Adv Hematol Oncol; 2012 May; 10(5):319-20. PubMed ID: 22706541
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hematopoietic stem cell transplantation (HSCT): characteristics of HSCT using bone marrow, peripheral blood and cord blood cells].
    Sakamaki H
    Rinsho Ketsueki; 2003 May; 44(5):283-93. PubMed ID: 12822402
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee.
    Fuentes Camps I; Rodríguez A; Agustí A
    Br J Clin Pharmacol; 2018 Jun; 84(6):1384-1388. PubMed ID: 29446851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.
    Scoggins JF; Ramsey SD
    J Natl Cancer Inst; 2010 Sep; 102(17):1371. PubMed ID: 20682918
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
    Bennett C; Waters T; Stinson T; Almagor O; Pavletic Z; Tarantolo S; Bishop M
    Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical stem cell transplantation-bone marrow vs peripheral blood.
    Gulbas Z
    Transfus Apher Sci; 2018 Apr; 57(2):168-170. PubMed ID: 29764770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization, more funds on horizon for clinical trials.
    McNeil C
    J Natl Cancer Inst; 2005 Apr; 97(8):555-7. PubMed ID: 15840874
    [No Abstract]   [Full Text] [Related]  

  • 18. American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?
    Califf RM; Harrington RA
    J Am Coll Cardiol; 2011 Aug; 58(7):677-80. PubMed ID: 21816302
    [No Abstract]   [Full Text] [Related]  

  • 19. International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.
    Kim ES; Carrigan TP; Menon V
    J Am Coll Cardiol; 2011 Aug; 58(7):671-6. PubMed ID: 21816301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
    Soni S; Boulad F; Cowan MJ; Scaradavou A; Dahake J; Edwards S; Walters MC
    Pediatr Blood Cancer; 2014 Sep; 61(9):1690-4. PubMed ID: 24803091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.